Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 5 of 135
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Arbutus discovers molecular targets to treat Covid-19

Canadian biopharmaceutical firm Arbutus Biopharma has identified many molecules that can inhibit the SARS-CoV-2 nsp5 main protease (Mpro), achieving its first milestone under Covid-19 discovery research and license